Menu
Recruiting NCT05438511

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

Observational Breast Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Focus group, Organizational Readiness for Implementing Change.
Who it may be relevant to
Registry conditions: Breast Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States, Tanzania
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.

Interventions

  • Behavioral Focus group
    A semi-structured focus group discussion guide will be developed with question probes that cover 1) contextual factors, 2) barriers to implementation, and 3) facilitators to implementation, with secondary probing questions.
  • Behavioral Organizational Readiness for Implementing Change
    measures the extent to which organizational members are prepared to implement organizational change. The ORIC tool asks participants to rate their level of agreement with 12 statements pertaining to organizational readiness for change (change commitment and change efficacy) on a 5-point Likert Scale.

Primary outcome measures

  • Identify barriers for breast cancer diagnosis in Tanzania. [Time frame: 1 year]

Eligibility criteria

Participant Inclusion Criteria for interviews and focus group discussions (Aims 1 and 2):

  • Breast cancer survivor, patient advocate or key healthcare personnel
  • Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with:
  • >12 months of employment at the affiliated institution
  • Administrative or clinical involvement in the delivery of breast cancer care services.
  • Age 18 years and above
  • Permanent residents or citizens of Tanzania
  • Participant and/or LAR willing and able to consent
  • Fluent in Swahili and/or English by self-report

Participant Exclusion Criteria:

  • Key stakeholder not residing at their particular institutions during data collection will be excluded.

Eligibility criteria for Chart Reviews (Aim 1)

Inclusion Criteria for chart review:

  • Age 18 years and above
  • Permanent residents or citizens of Tanzania
  • Received breast cancer diagnosis

Exclusion Criteria for chart review:

  • Participants less than 18 years of age

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York
Tanzania · 1 center
  • Muhimbili University of Health and Allied Sciences — Dar es Salaam

Identifiers

NCT: NCT05438511 · 21-480

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗